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Background: Most people with multiple sclerosis (PwMS) experience progressively worsening disability over a
period of decades, thus further knowledge about the long-term changes in different areas of disability is essential.
Objectives: The aims of this study were to evaluate changes in disability over ten years in PwMS, and to explore
the value of personal and disease-speciﬁc factors and depressive symptoms in predicting disability. A further
aim was to explore the value of these factors as predictors of mortality.
Methods: This study was based on a 10-year follow-up of a population-based study in Stockholm (n = 166).
Home visits were used to collect data on personal and disease-speciﬁc factors, walking ability, manual dexterity,
cognitive function, mood, activities of daily living (ADL) and social/lifestyle activities.
Results: The proportion of the study population who had disability in cognition, mood and social/lifestyle activ-
ities remained stable, while the proportion with disability in walking, manual dexterity and ADL increased. Dis-
ease severity predicted an increase in all studied variables of disability except in depressive symptoms. Older
age and depressive symptoms were associated with mortality.
Conclusion: This study illustrates the importance of tailored interventions for PwMS and highlights the need for
health-care professionals to consider the psychological aspects of the disease. Furthermore, our results indicate
that the Expanded Disability Status Scale was a useful tool for predicting future disability.© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Multiple sclerosis (MS) is a neuroinﬂammatory and neurodegenera-
tive diseasewhich has a variable course in different individuals over the
course of several decades [1]. Even though disability in people with MS
(PwMS) often occurs in many areas of functioning [2], population-
based long-term follow-ups (10 years or more) of PwMS often focus
on changes in overall scores of disease severity [3], assessed by the
Expanded Disability Status Scale (EDSS) [4]. Long-term follow-ups of
other impairments often study only one impairment, e.g., cognition,
are based on selected cohorts, and the follow-up period is often less
than a decade [5]. Age, the type of MS and the type of symptoms atKarolinska University Hospital,
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zander).
B.V. Open access under CC BY-NC-ND onset, as well as sex and the degree of remission after the ﬁrst bout
have all been found to be valuable predictors of long-term disease pro-
gression, as assessed by the EDSS [6]. Factors that can predict disability
in speciﬁc areas are rare.
The inﬂuence of age at diagnosis, sex and disease-speciﬁc factors
on mortality in PwMS has been well studied [7]; however, the inﬂu-
ence of personal factors such as coping capacity and level of education
is unknown. Depressive symptoms are associated with impaired cog-
nition, decreased frequency of social/lifestyle activities and limita-
tions in the ability to work [8]; however, the value of depressive
symptoms in predicting long-term disability and mortality requires
exploration. In addition, considering the high prevalence of cognitive
impairment in PwMS [5], it is important to study whether there is an
association between cognitive impairment and mortality.
In order to prioritise different treatment options andprovide tailored
interventions, knowledge resulting from longitudinal population-based
studies which take into account the complex relationship between
health, disability, and personal and environmental factors [9] is re-
quired. Hence, the aims of this study were to explore changes in disabil-
ity in a 10-year follow-up of a population-based cohort of PwMS, and tolicense.
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symptoms as predictors of disability. A further aim was to explore the
value of personal and disease-speciﬁc factors, depressive symptoms
and cognitive impairment as predictors of mortality.
2. Materials and methods
2.1. Participants
This study is based on a 10-year follow-up of a population-based
study in Stockholm, Sweden, the recruitment process of which has
been described in detail previously [10]. In brief, the PwMS included
at baseline (from September 1999 to September 2002) were recruited
from a temporary data pool consisting of 2129 patients from all hospital
neurology clinics in Stockholm County, in order to obtain the highest
possible population-based ascertainment. A random sample was
drawn, representing 15% (n = 321) of the data pool. Inclusion criteria
were: a deﬁnite and informed diagnosis of MS, being a resident in
Stockholm County and having no diagnosis of other severe neurological
or psychiatric illness. Of the 196 PwMS who fulﬁlled the inclusion
criteria, 166 (85%) gave informed consent and agreed to participate. In
order to collect data for the 10-year follow-up, the same PwMS were
identiﬁed and those still alive were contacted by post.
2.2. Data collection
Data collection was performed by home visits at a date 10 years ±
6 months after baseline (from May 2009 to February 2012). Data
were obtained using structured face-to-face interviews using the
same protocol as was used at baseline. Each home-visit lasted for 2 to
3 h and was conducted either by one of three physiotherapists or by
an occupational therapist, all of whom had clinical experience of neuro-
logical assessment and were trained for the purpose of data collection.
Death certiﬁcates for the 32 PwMS who had died in the ten years
since the baseline study were collected from the National Board of
Health and Welfare with information about the date and cause of
death. The Regional Ethical Review Board in Stockholm approved the
study.Table 1
Variables studied, instruments used, and criteria for categorisation of the independent variab
in the analyses of predictors for increase in proportions with disability.
Variables and instruments Categorisation criteria
Age b51 years of age/≥51 years of ag
Sex Female/male
Coping capacity:
Sense of Coherence Scale
Norm data from a reference group
Education Basic/high school or university
Time since diagnosis ≤10 years/N10 years
Disease severity:
Expanded Disability Status Scale
EDSS mild: 0–3.5/EDSS moderate
Disease course Relapsing–remitting/progressive
Walking speed:Timed 2 × 5 m walk testa
Use of walking aid
Age- and sex-related norms [21].
Walk without aid/walk with aid/c
Manual dexterity:
Nine-Hole Peg Testb
Norm data from a reference group
Cognitive function:
Mini Mental State Examination
Symbol Digit Modalities Testc
Impairment: b28/no impairment:
Age-related norms [15]. Impairme
Mood:
Beck Depression Inventory II
Depressive symptoms: ≥13/no de
Activities of daily living:Barthel Index
Katz ADL Index Extended
Dependence: b100/independence
Dependence: b28/independence:
Social/lifestyle activities:
Frenchay Activities Index
Age- and sex-related norms [23].
b25th percentile/not reduced freq
a Speed calculation was set to 0 m/s for PwMS unable to walk.
b Speed calculation was set to 0 pegs/s for PwMS unable to perform the test.
c Speed calculation was set to 0 for PwMS unable to perform the test.Information about use of immunomodulatory treatment and antide-
pressant drugs, civil status, level of education and work status was col-
lected by interview. To assess coping capacity, the 13-item version of
the sense of coherence scale (SOC) was used [11]. The data collectors
assessed disease severity by using the EDSS [4]; in addition they
assessed disease course. The assessments were veriﬁed by a senior neu-
rologist (SF), as was the use of immunomodulatory treatment. Data
about the time since diagnosis was collected at baseline from medical
records. A 10-metre walking test was used to assess walking speed
and was performed, with a turn, on a 5-metre course (the Timed
2 × 5 m walk test) [12]; a static start was used, the PwMS were
instructed to walk as quickly as possible and the use of walking aids
was documented. Manual dexterity was assessed with the Nine-Hole
Peg Test (NHPT) for the right hand [13]. Cognitive functionwas assessed
with the Mini-Mental State Examination (MMSE) [14] and the Symbol
Digit Modalities Test (SDMT) [15]. The MMSE was used for screening
of global cognitive performance. The SDMT assesses the capacity to di-
rect attention quickly and accurately and was primarily administered
with a written response; for those PwMS unable to write, the test was
administered with an oral response. Disability in mood (depressive
symptoms) was assessed using the Beck Depression Inventory II (BDI)
[16]. The BDI consists of 21 items related to depression, each of which
is self-assessed from 0 (absent) to 2 or 3 (severe). Dependency in per-
sonal and instrumental activities of daily living (ADL) was assessed
with the Barthel Index (BI) [17] and the Katz Extended ADL Index (KE)
[18], respectively, and frequency of social/lifestyle activities with the
Frenchay Activities Index (FAI) [19]. The variables studied, instruments
used and the criteria for the categorisation of variables are summarised
in Table 1.
2.3. Statistical analysis
Descriptive statistics were used to present personal and disease-
speciﬁc characteristics, and the presence of disability.
Due to non-normally distributed data, the Sign test was used for
analyses of statistically signiﬁcant changes in scores from baseline
to the 10-year follow-up. Statistically signiﬁcant changes in the pro-
portion of PwMS with disability at baseline and at follow-up were
analysed with the McNemar test. p value for changes was set toles and the dependent variables used in the analyses of proportions with disability and
e
[20]. SOC weak: 13–54 points/SOC moderate or strong: 55–91 points
: 4.0–5.5/EDSS severe: 6.0–9.5
Limitation: ≥−1 SD from average speed/no limitation: b−1 SD from average speed
annot walk
[22]. Impairment: ≤0.5 peg/s/no impairment: N0.5 peg/s
≥28 [14]
nt: ≥−1.5 SD from the mean/no impairment: b−1.5 SD from the mean
pressive symptoms: b13 [8]
: = 100
= 28
Reduced frequency:
uency: ≥25th percentile
Table 2
Personal and disease-speciﬁc characteristics of people with MS at baseline and at the
10-year follow-up and p values for the changes in personal and disease-speciﬁc char-
acteristics between baseline and follow-up n = 118.
Baseline Follow-up p value
Mean age, years (SD) 49 (11)
Female, n (%) 85 (72)
Moderate or strong sense of coherence, na (%) 96 (87) 95 (86) 0.842
High school or university education, n (%) 88 (75) 90 (76) 0.804
Working full- or part-time, nb (%) 62 (56) 37 (43) 0.055
Immunomodulatory treatment, n (%) 48 (41) 20 (21) b0.001
Antidepressant drugs n (%) 12 (10) 27 (23) b0.001
Time since diagnosis, mean (SD) 18 (11)
Disease severity, n (%)c
EDSS mild
EDSS moderate
EDSS severe
41 (36)
24 (20)
51 (44)
19 (16)
22 (19)
77 (65)
b0.001
0.750
b0.001
Relapsing–remitting disease course, n (%) 55 (48) 24 (21) b0.001
a n = 110.
b Based on PwMS b65 years, n = 109 at baseline, n = 86 at follow-up.
c Mean EDSS 5.0 at baseline, 6.0 at follow-up.
Table 3
Proportions of people with MS with disability at baseline and at the 10-year follow-up,
p values for changes in the proportion with each disability n = 118.
Test (range) Baseline
disability
n (%)
Follow-up
disability
n (%)
p value
Timed 2 × 5 m walk testa 100 (85) 108 (91) 0.027
Nine-Hole Peg Test 65 (55) 77 (65) 0.014
Mini-Mental State Examination 41 (35) 68 (58) b0.001
Symbol Digit Modalities Testb 49 (42) 48 (41) 1.000
Beck Depression Inventoryc 21d (18) 23e (19) 0.823
Barthel Index 44 (37) 73 (62) b0.001
Katz Extended ADL Index 71 (60) 87 (74) 0.002
Frenchay Activities Indexf 66 (56) 73 (62) 0.345
a 113 (96%) completed the test at baseline and at follow-up.
b 105 (89%) completed the test at baseline and at follow-up.
c 113 (96%) completed the test at baseline and at follow-up.
d 6 PwMS used antidepressant drugs.
e 5 PwMS used antidepressant drugs.
f 117 (99%) completed the test at baseline and at follow-up.
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who survived at the 10-year follow-up.
Generalized Estimating Equations (GEE) were conducted to investi-
gate the increase over 10 years, in the proportion of the PwMSwith lim-
itation in walking (use of walking aid), impaired cognition (SDMT),
depressive symptoms (BDI), dependence in ADL (KE), and reduced fre-
quency of social/lifestyle activities (FAI) from baseline to the 10-year
follow-up (for categorisation of the dependent variables see Table 1).
Independent variables at baseline were included in all the models,
together with the time variable (0 and 10 years). The independent
variableswere age, sex, coping capacity, level of education, disease sever-
ity, disease course, time since diagnosis and mood. Since linearity in the
logit scale could not be assumed, the independent variables were
categorised. In the model with depressive symptoms as the dependent
variable, mood was not included as an independent variable. Stepwise
backward selection criteria were employed, entering all independent
variables and then removing those variables with a p value N 0.05. For
each dependent variable, one ﬁnal model was created where all inde-
pendent variables with a p value ≤ 0.05 were retained. Interactions be-
tween time and the independent variable were controlled for and
when the interactions were signiﬁcant the main effects were also
retained in the ﬁnal model irrespective of statistical signiﬁcance. The re-
sults are presented as odds ratios (OR) with 95% CI and p values. In case
of signiﬁcant interactions, simple effectswere presented, i.e. effect of one
variable holding the other variable ﬁxed.
In order to analyse the predictive value of different independent
variables on mortality, regardless of cause of death, univariate Cox re-
gression analyses were performed followed by a multivariate Cox re-
gression using stepwise forward selection criteria. For the stepwise
selection, the criterion for entry was set to a p value ≤ 0.05, and a p
value ≥ 0.10 was used as the criterion for removal. The selection of
the independent variables in the models was based on: 1) variables
previously identiﬁed as predictors (age, sex, time since diagnosis, dis-
ease severity, disease course), and: 2) variables that have not been
explored as predictors in previous studies (coping capacity, level of
education, cognition and mood). The results are presented as hazard
ratios with 95% conﬁdence intervals (CI) and p values. The SPSS, ver-
sion 20.0 (SPSS Inc., Chicago, Illinois, USA) and the SAS® System 9.1,
SAS Institute Inc., Cary, NC, USA were used for the statistical analyses.
3. Results
Of the 166 PwMS included at baseline, 32 PwMS were deceased at
the 10-year follow-up, 11 declined to participate, four were not able
to be interviewed due to severe disability and one had not answered
most of the questions and was, therefore, excluded. Consequently, a
total of 118 PwMSwere included in the analyses of changes in disabil-
ity over 10 years.
Personal and disease-speciﬁc characteristics at baseline and at the
10-year follow-up are summarised in Table 2. The proportion of
PwMS with immunomodulatory treatment had decreased from 41%
to 21%, whereas the proportion of PwMS who used antidepressant
drugs had increased from 10% to 27%. The proportion categorised as
EDSS mild had decreased from 36% to 16%, and the proportion
categorised as EDSS severe had increased from 44% to 65%. The pro-
portion of PwMS categorised with a relapsing-remitting course had
decreased from 48% to 21%.
Median EDSS scores had changed from 5.0 at baseline to 6.5 at the
10-year follow-up. The reasons for failing to complete the tests were
inability due to MS and refusal. There were statistically signiﬁcant
changes (p value b 0.001) in median scores in all areas of functioning,
implying worse functioning, except in mood (p value = 0.300).
The proportion of PwMS with disability at baseline and at the
10-year follow-up are presented in Table 3. There was an increase
in the proportion of disabled PwMS from baseline to follow-up in all
areas except in depressive symptoms, cognitive impairment assessedby the SDMT, and reduced frequency of social/lifestyle activities. Of
those with depressive symptoms, six (29%) used anti-depressant
drugs at baseline and ﬁve (22%) at follow-up. At baseline 17 (15%)
could not walk at all and at follow-up 24 (21%). Of the 113 PwMS
who participated in the timed 2 × 5 m walk test, 17 (15%) walked
with an aid at baseline and 37 (33%) at follow-up, 79 (70%) walked
without aid at baseline and 52 (46%) at follow-up.
The ﬁnal GEE models for the dependent variables limitations in
walking, impaired cognition, depressive symptoms, dependence in
ADL and reduced frequency of social/lifestyle activities are presented
in Table 4. Disease severity predicted an increase in proportion with
disability in all dependent variables studied except depressive symp-
toms. The time effect variable was signiﬁcant for predicting an in-
crease in proportion with limitation in walking and dependence in
ADL with an OR of 11.3 and 3.1 respectively from baseline to the
10-year follow-up. For limitation in walking, there was also a signiﬁ-
cant interaction between the time effect variable and “time since di-
agnosis” which was most pronounced for those with a shorter time
since diagnosis (≤10 years) with an OR of 30.5. For dependence in
ADL, the time effect variable interacted with “age” with an OR of 5.5
for those with an age ≥51 years. For reduced frequency of social/
lifestyle activities the time effect variable interacted with “age” with
anOR of 2.7 for thosewith an age≥51 years. There was also an interac-
tion between the time effect variable and “disease severity”, with an OR
Table 4
Estimated odds ratios (OR), 95% conﬁdence intervals (CI) and p values for the predictive value of the time factor (0 and 10 year) and the independent variables on an increase over
10 years in proportion with limitation in walking, impaired cognition, depressive symptoms, dependence in activities of daily living and reduced frequency of social/lifestyle activ-
ities in people with MS according to the ﬁnala Generalized Estimating Equation models n = 118.
Dependent variable Independent variable categorisation OR (CI) p value
Limitation in walkingb Time since diagnosis N10 years 1.9 (0.8–4.9) ns
Time since diagnosis ≤10 years 1 (ref)
Time 10-year follow up 11.3 (5.0–25.3) b0.001
Baseline 1 (ref)
≤10 years since diagnosis/time: 10-year follow-up 30.5 (6.6–140.3) b0.001
Baseline 1 (ref)
N10 years since diagnosis/time: 10-year follow-up 4.2 (2.4–7.2) b0.001
Baseline 1 (ref)
Moderate EDSS 6.9 (2.1–22.8) 0.002
Mild EDSS 1 (ref)
Severe EDSS 194.7 (60.1–631.1) b0.001
Mild EDSS 1 (ref)
Impaired cognitionc Male 2.5 (1.1–5.4) 0.023
Female 1 (ref)
Moderate EDSS 2.9 (1.1–7.9) 0.036
Mild EDSS 1 (ref)
Severe EDSS 3.1 (1.3–7.0) 0.008
Mild EDSS 1 (ref)
Depressive symptomsd SOC weak 4.05 (1.38–11.85) 0.011
SOC moderate or strong 1 (ref)
Dependence in activities of daily livinge Age ≥51 years 1.4 (0.6–3.2) ns
Age ≥51 years 1 (ref)
Time 10-year follow up 3.1 (1.7–5.9) b0.001
Baseline 1 (ref)
Age b51 years/time: 10-year follow up 1.8 (0.9–3.6) ns
Baseline 1 (ref)
Age ≥51 years/time: 10-year follow-up 5.5 (2.1–14.7) b0.001
Baseline 1 (ref)
Moderate EDSS 5.2 (2.1–13.2) b0.001
Mild EDSS 1 (ref)
Severe EDSS 45.9 (13.6–154.3) b0.001
Mild EDSS 1 (ref)
Reduced frequency of social/
lifestyle activitiesf
Age ≥51 years 0.9 (0.4–2.2) ns
Age b51 years 1 (ref)
Time 10-year follow up 1.3 (0.7–2.2) ns
Baseline 1 (ref)
Age b51 years/time: 10-year follow-up 0.6 (0.3–1.3) ns
Baseline 1 (ref)
Age ≥51 years/Time: 10-year follow-up 2.7 (1.1–6.9) 0.033
Baseline 1 (ref)
SOC weak 3.4 (1.3–9.2) 0.015
SOC moderate or strong 1 (ref)
Moderate EDSS 3.1 (1.2–8.0) 0.021
Mild EDSS 1 (ref)
Severe EDSS 28.0 (9.4–83.7) b0.001
Mild EDSS 1 (ref)
Mild EDSS/time: 10-year follow-up 4.3 (1.5–12.4) 0.006
Baseline 1 (ref)
Moderate EDSS/time: 10-year follow-up 1.5 (0.5–4.5) ns
Baseline 1 (ref)
Severe EDSS/time: 10-year ollow-up 0.3 (0.1–0.7) 0.004
Baseline 1 (ref)
a Independent variables and interactions with p values ≤ 0.05 were retained in the ﬁnal models. When the interactions were signiﬁcant the main effects also were retained in the
ﬁnal model irrespective of statistical signiﬁcance.
b Timed 2 × 5 m walk test.
c Symbol Digit Modalities Test.
d Beck Depression Inventory.
e Katz Extended ADL Index.
f Frenchay Activities Index.
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severe EDSS at baseline.
Among the 32 deceased PwMS, mean age at the time of death was
63 years for women and 70 years for men. At baseline, median disease
severity was EDSS 7.0, 27 PwMS had a progressive course, 12 were
receiving immunomodulatory treatment, and 5 were receiving antide-
pressant drugs. Univariate analyses and the ﬁnalmodel of themultivar-
iate Cox regression analysis for the prediction of the independent
variables of mortality are presented in Table 5. Age ≥51 years, severe
EDSS and a progressive disease course were associated with mortalityin the univariate analyses. Age ≥51 years and depressive symptoms
were associated with mortality in the multivariate analyses. The esti-
mated log-odds and the standard errors in the GEE analyses and in
the multivariate Cox regression analysis were of reasonable magnitude
and thus revealed no signs of collinearity.
The death certiﬁcates revealed that MS was an underlying cause of
death for 16, and a contributing cause of death for seven of the 32 de-
ceased PwMS. The underlying causes of death for the remaining 16
deceased PwMS were cancer, respiratory diseases, accidents, cardio-
vascular diseases, infectious diseases or other diseases.
Table 5
Hazard ratios, 95% conﬁdence intervals (CI) and p values for the association between the independent variables on mortality in people with MS over the 10-year period according to
univariate analyses and the ﬁnal model of the multivariate Cox regression analyses (n = 155a).
Independent variable Variable categorisation Univariate analyses Final model
Hazard ratio (CI) p value Hazards ratio (CI) p value
Age ≥51 years of age
b51 years of age
3.4 (1.5–7.6)
1
0.003 14.6 (1.5–14.4)
1
0.009
Sex Male
Female
1.5 (0.7–3.6)
1
0.312 ns
Sense of coherence Weak
Moderate or strong
1.3 (0.4–4.5)
1
0.650 ns
Education Basic
High school or university
1.4 (0.7–3.0)
1
0.349 ns
Time since
diagnosis
N10 years
≤10 years
1.9 (0.9–4.1)
1
0.078 ns
Disease severity EDSS severe
EDSS moderate
EDSS mild
4.0 (1.4–11.6)
0.9 (0.2–4.9)
1
0.009
0.898
ns
Disease course Progressive
Relapsing–remitting
3.9 (1.5–10.1)
1
0.005 3.3 (0.9–11.5)
1
0.066
Cognition Cognitive impairment
No cognitive impairment
1.4 (0.6–3.0)
1
0.431 ns
Mood Depressive symptoms
No depressive symptoms
1.8 (0.7–4.8)
1
0.204 2.7 (1.04–7.24)
1
0.041
a The multivariate Cox regression analyses included all PwMS available at baseline except the 11 PwMS who declined to participate in the 10-year follow-up.
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This population-based longitudinal study demonstrated that dis-
ease severity (EDSS) and the proportion of PwMS with disability in
walking, manual dexterity and personal and instrumental ADL in-
creased over a 10-year period, but that the proportions with cognitive
impairment, depressive symptoms and reduced frequency in social/
lifestyle activities remained stable. Changes in median scores were
found in all assessed areas except in mood.
In the ﬁnal GEE models, disease severity (EDSS) predicted an in-
crease in the proportion with disability in all assessed areas except
the proportion with depressive symptoms at the 10-year follow-up.
The time effect variable was signiﬁcant for an increase in proportion
with limitation in walking and dependence in ADL. Older age and de-
pressive symptoms at baseline were associated with mortality over
the 10-year period.
The mean change in disease severity (EDSS) over the 10-year pe-
riod was one point, which is consistent with previous ﬁndings [3],
and the mean change from EDSS 5.0 to 6.0 found in this study indi-
cates the passing of an important milestone, i.e., the need for a walk-
ing aid [24]. Walking speed was reduced at baseline and was further
impaired at follow-up. Severe EDSS at baseline predicted, as expected
since the EDSS places signiﬁcant emphasis on the ability to walk, an
increased proportion with limitation in walking. The time effect vari-
able was more pronounced for those PwMS with shorter time since
diagnosis at baseline compared to those with longer time since diag-
nosis. A possible explanation for this result is that those with longer
time since diagnosis at baseline already had limitation in walking.
The high odds ratios in the model for limitation in walking imply an
extremely high event rate for this outcome. Early rehabilitation
that focuses on walking [25] is likely to preserve independence in
ADL and frequency of social/lifestyle activities [26]. The proportion
of PwMS with disability in manual dexterity increased to 65% at
follow-up. This highlights that manual dexterity should also be thor-
oughly assessed and that studies on the effect of interventions that
aim to sustain/improve manual dexterity are required [26].
The proportion of PwMS dependent in personal and instrumental
ADL increased to 62% and 74% respectively. Amore severe EDSS at base-
line predicted an increase in this outcomewhich could be expected con-
sidering the association between walking and ADL [26]. It could also be
expected that the time effect variable was signiﬁcant only for those
with an older age at baseline in predicting dependence in ADL sincedependence in ADL increases with age. Interestingly, the time effect
variable had an inverse effect on reduced frequency of social/lifestyle
activities for those PwMS with a severe EDSS at baseline. There may
be an adaptation process to the consequences of the disease over
time, facilitated by personal factors such as moderate or strong SOC
and/or facilitating environmental factors such as the use of health-
care services that enable participation in society despite increased
disability [9].
Although the proportion of PwMS with cognitive impairment was
stable over time according to the SDMT, a signiﬁcant decrease in the
raw score of the SDMT was seen. A possible explanation for this result
can be that the raw score of the SDMT was compared to age-related
norms. Both the proportion with cognitive impairment and the raw
score of the MMSE signiﬁcantly changed over time implying a de-
creased cognitive function. The SDMT is an instrument recommended
for use in PwMS [35] while the result from the MMSE should be
interpreted with greater caution due to its low sensitivity and speci-
ﬁcity in PwMS [14]. Those PwMS with mild EDSS were more likely
to remain cognitively intact than those with moderate and severe
EDSS. A previous review stated that cognitive impairment encom-
passes all disease stages but there seems to be an association between
increasing disability level and worse cognitive decline [5]. Male sex
was also a predictor for an increase in proportion with cognitive im-
pairment over time, which supports previous ﬁndings [27]. What
clinical implications this might have, requires further study. In addi-
tion, considering the impact of cognitive impairment on working abil-
ity [28], further studies of the effectiveness of speciﬁc interventions,
such as vocational rehabilitation, are needed.
The proportion of PwMS with depressive symptoms (almost 20%)
was stable over the 10-year period. In this study a weak SOC was the
only predictor of depressive symptoms, and the importance of coping
capacity to manage depression among PwMS has been found in previ-
ous longitudinal studies [29]. Depressive symptoms in PwMS have
been found to be undertreated pharmacologically [30], and PwMSexpe-
rience a lack of psychological interventions [31]. Therewas an increased
use of antidepressant drugs, though not among those with depressive
symptoms, which could be explained by an increased treatment of,
e.g., neurogenic pain. It is not known if thosewith depressive symptoms
had access to other treatment, i.e., psychological interventions. The ef-
fort to detect and provide evidence-based care for depressive symp-
toms, therefore, needs to be continued. A care manager responsible
for the support of, and continuous contact with the depressed person,
126 C. Chruzander et al. / Journal of the Neurological Sciences 332 (2013) 121–127is recommended as a feasible model [32] and might also be effective in
the care of PwMS. Recent studies of cognitive behavioural therapy for
depressive symptoms in PwMS have shown promising results [33],
but further studies are needed in order to conclude if this is a feasible
method for PwMS regardless of concurrent disability [2]. Although de-
pressive symptoms are considered to be functionally impairing [8],
this was not conﬁrmed in our analyses of predictors for limitation in
walking, impaired cognition, dependence in ADL and reduced frequen-
cy of social/lifestyle activities.
Of the deceased PwMS, 72% had MS listed on their death certiﬁ-
cate as an underlying or contributing cause of death. The remaining
28% died from cardiovascular disease, pulmonary infections and acci-
dents. These causes may directly or indirectly be attributed to MS
[34]. By underestimating MS as an underlying or contributing cause
of death, important MS-related interventions to prevent secondary
conditions, such as physical deconditioning, throughout the progress
of the disease, may be neglected [25]. Depressive symptoms at base-
line were associated with mortality over the 10-year period. Although
this result needs to be conﬁrmed in larger population-based studies,
it highlights that health-care professionals need to be aware of the
psychological aspects of the disease.
The instrument's sensitivity to change is a strength in the present
study. However, some methodological limitations of this study are im-
portant to consider. By having only two points of data collection with
ten years in between, we cannot take into account variations that
might have occurred during this period and that could have affected
the outcome in disability. It is possible that there is an underestimation
of the real changes in disability and mortality in our follow-up sample
considering that 30 PwMS included in the baseline study did not
agree to participate, and there was a loss of 16 PwMS at follow-up. It
is likely that reasons for not participating were, at least in some cases,
related to disability. It is likely that the proportion of PwMSwith disabil-
ity in different assessed areas would have been higher, if those PwMS
who died were included in the analyses of changes in disability over
time. The results should therefore be interpreted with these limitations
in mind. Since the number of participants in the GEE analyses and the
multivariate Cox regression analysis were relatively low, the results
need to be conﬁrmed in larger population-based studies. The multiple
testing of related outcomes in the GEE analyses increases the risk of
Type I error. However, given the exploratory nature of these analyses,
it was considered important to diminish the risk of Type II error,
hence, the alpha level was not adjusted. Other areas of disability
known to occur in PwMS (e.g., fatigue, bladder and bowel problems,
loss of libido, speech and swallowing problems) [1] were not studied.
In conclusion, this study demonstrated that the proportion with
disability in cognition, mood and in social/lifestyle activities remained
stable over a 10-year period, while the proportion with disability
in walking, manual dexterity and personal and instrumental ADL in-
creased. The time effect variable was signiﬁcant for outcomes of a
more physical character. Disease severity, assessed by the EDSS, pre-
dicted disability in limitation inwalking, impaired cognition and depen-
dence in ADL, which indicates that the EDSS is a useful tool for
predicting future disability in these areas. The high proportion with de-
pressive symptoms and the possible association between depressive
symptoms and mortality highlight the need for health-care profes-
sionals to consider the psychological aspects of the disease, and also
that further studies of the suitability of, for example, cognitive behav-
ioural therapy, are required. In order to organise individually tailored
health-care, it is necessary to obtain a broader understanding of the
health condition of PwMSover the course of a decade. Thus, future stud-
ies of, for example, the use of health-care and changes in health-related
quality of life over the course of a decade, are necessary.
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